MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study
Abstract Background With the shift of research focus towards the pre-dementia stage of Alzheimer’s disease (AD), there is an urgent need for reliable, non-invasive biomarkers to predict amyloid pathology. The aim of this study was to assess whether easily obtainable measures from structural MRI, com...
Main Authors: | Mara ten Kate, Alberto Redolfi, Enrico Peira, Isabelle Bos, Stephanie J. Vos, Rik Vandenberghe, Silvy Gabel, Jolien Schaeverbeke, Philip Scheltens, Olivier Blin, Jill C. Richardson, Regis Bordet, Anders Wallin, Carl Eckerstrom, José Luis Molinuevo, Sebastiaan Engelborghs, Christine Van Broeckhoven, Pablo Martinez-Lage, Julius Popp, Magdalini Tsolaki, Frans R. J. Verhey, Alison L. Baird, Cristina Legido-Quigley, Lars Bertram, Valerija Dobricic, Henrik Zetterberg, Simon Lovestone, Johannes Streffer, Silvia Bianchetti, Gerald P. Novak, Jerome Revillard, Mark F. Gordon, Zhiyong Xie, Viktor Wottschel, Giovanni Frisoni, Pieter Jelle Visser, Frederik Barkhof |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Alzheimer’s Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13195-018-0428-1 |
Similar Items
-
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics
by: Isabelle Bos, et al.
Published: (2018-07-01) -
The EMIF-AD PreclinAD study: study design and baseline cohort overview
by: Elles Konijnenberg, et al.
Published: (2018-08-01) -
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study
by: Nienke Legdeur, et al.
Published: (2018-11-01) -
Identifying Cases of Type 2 Diabetes in Heterogeneous Data Sources: Strategy from the EMIF Project.
by: Giuseppe Roberto, et al.
Published: (2016-01-01) -
CSF Proteomic Alzheimer’s Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals
by: Betty Marije Tijms, et al.
Published: (2021-08-01)